Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Enanta Pharmaceuticals (ENTA) Shares Outstanding: 2012-2025

Historic Shares Outstanding for Enanta Pharmaceuticals (ENTA) over the last 8 years, with Sep 2025 value amounting to $21.4 million.

  • Enanta Pharmaceuticals' Shares Outstanding rose 0.91% to $21.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 0.91%. This contributed to the annual value of $21.4 million for FY2025, which is 0.91% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Shares Outstanding of $21.4 million as of Q3 2025, which was up 0.04% from $21.4 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Shares Outstanding high stood at $21.4 million for Q3 2025, and its period low was $20.2 million during Q1 2021.
  • In the last 3 years, Enanta Pharmaceuticals' Shares Outstanding had a median value of $21.2 million in 2024 and averaged $21.2 million.
  • Data for Enanta Pharmaceuticals' Shares Outstanding shows a peak YoY increased of 2.73% (in 2022) over the last 5 years.
  • Over the past 5 years, Enanta Pharmaceuticals' Shares Outstanding (Quarterly) stood at $20.5 million in 2021, then increased by 1.84% to $20.9 million in 2022, then grew by 1.30% to $21.2 million in 2023, then increased by 0.84% to $21.3 million in 2024, then climbed by 0.91% to $21.4 million in 2025.
  • Its Shares Outstanding stands at $21.4 million for Q3 2025, versus $21.4 million for Q2 2025 and $21.4 million for Q1 2025.